Diabetes Mellitus and Pregnancy : Knowledge Assessment (DMPKA)
June 15, 2022 updated by: CHU de Reims
Evaluation of Knowledge About Contraception and Pregnancy Planning Among Type 1 and Type 2 Diabetes Women
Diabetes, a chronic and frequent disease, is a risk factor of pregnancy complications such as preeclampsia, congenital malformations and macrosomia.
Preconception care is all methods to assess the best prognostic for a diabetic pregnancy. Among these methods, contraception is very important to plan the pregnancy on a chosen moment.
The content of the preconception care is well established. However, information of diabetic women concerning contraception and giabetic pregnancy has been little studied.
Study Overview
Detailed Description
The aim of the study is to describe the knowledge of the patients with diabetes concerning contraception and pregnancy planning.
Study Type
Observational
Enrollment (Actual)
122
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Reims, France
- Damien JOLLY
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women between 18 and 40 years old, consulting in diabetology department of Reims Universitary Hospital and Charleville Mézières General Hospital
Description
inclusion criteria :
- Patients Aged between 18 and 40 years old
- With type 1 or type 2 diabetes mellitus
- Consulting in the department of diabetology in Reims and Charleville Mezieres hospitals
- Accepting to participate in the study
exclusion criteria :
- Patients With secondary diabetes (endocrine, pancreatic or genetical origin)
- With postmenopausal status
- Without capacity to have a pregnancy (uterine aplasia, hysterectomy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Diabetic patients
Women between 18 and 40 years old with type 1 and type 2 diabetes
|
Data record
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk of unplanned pregnancy
Time Frame: Day 0
|
Knowledge concerning the risk of unplanned pregnancy in diabete women
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 12, 2020
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
September 30, 2020
Study Registration Dates
First Submitted
April 15, 2020
First Submitted That Met QC Criteria
April 16, 2020
First Posted (Actual)
April 17, 2020
Study Record Updates
Last Update Posted (Actual)
June 16, 2022
Last Update Submitted That Met QC Criteria
June 15, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PO20041
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.